Positive News SentimentPositive NewsNASDAQ:AZTA Azenta (AZTA) Stock Forecast, Price & News $48.24 -0.42 (-0.86%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$48.08▼$48.9550-Day Range$44.08▼$57.7652-Week Range$36.01▼$63.60Volume499,788 shsAverage Volume1.06 million shsMarket Capitalization$2.90 billionP/E RatioN/ADividend YieldN/APrice Target$64.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Azenta MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside33.7% Upside$64.50 Price TargetShort InterestBearish10.54% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.67Based on 4 Articles This WeekInsider TradingSelling Shares$246,762 Sold Last QuarterProj. Earnings Growth123.08%From $0.13 to $0.29 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.37 out of 5 starsMedical Sector298th out of 968 stocksSpecial Industry Machinery, Not Elsewhere Classified Industry5th out of 13 stocks 3.3 Analyst's Opinion Consensus RatingAzenta has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $64.50, Azenta has a forecasted upside of 33.7% from its current price of $48.24.Amount of Analyst CoverageAzenta has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted10.54% of the float of Azenta has been sold short.Short Interest Ratio / Days to CoverAzenta has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in Azenta has recently decreased by 2.51%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAzenta does not currently pay a dividend.Dividend GrowthAzenta does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AZTA. Previous Next 3.2 News and Social Media Coverage News SentimentAzenta has a news sentiment score of 1.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Azenta this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for AZTA on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Azenta to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Azenta insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $246,762.00 in company stock.Percentage Held by InsidersOnly 1.67% of the stock of Azenta is held by insiders.Percentage Held by Institutions99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Azenta are expected to grow by 123.08% in the coming year, from $0.13 to $0.29 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Azenta is -92.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Azenta is -92.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAzenta has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Azenta (NASDAQ:AZTA) StockAzenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.Read More AZTA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AZTA Stock News HeadlinesSeptember 8, 2023 | finance.yahoo.comAzenta to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceSeptember 7, 2023 | finance.yahoo.comAzenta to Participate in the Baird 2023 Global Healthcare ConferenceSeptember 22, 2023 | Chaikin Analytics (Ad)This Stock Could Go Up 66% or More.Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.September 5, 2023 | finance.yahoo.comEstimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)August 18, 2023 | thestreet.comAzenta Inc.August 15, 2023 | msn.comAzenta ticks higher amid 13F filing from activist Politan CapitalAugust 10, 2023 | benzinga.comAzenta Director Trades $1.05M In Company StockAugust 10, 2023 | finance.yahoo.comAzenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023September 22, 2023 | Chaikin Analytics (Ad)This Stock Could Go Up 66% or More.Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.August 10, 2023 | seekingalpha.comAzenta, Inc. 2023 Q3 - Results - Earnings Call PresentationAugust 9, 2023 | msn.comWhy did Azenta stock go up today? Q3 beatAugust 9, 2023 | finance.yahoo.comAzenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 ConferenceAugust 9, 2023 | finance.yahoo.comAzenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023August 9, 2023 | finance.yahoo.comAzenta (NASDAQ:AZTA) lifts 4.0% this week, taking five-year gains to 70%August 8, 2023 | msn.comAzenta (AZTA) Beats Q3 Earnings and Revenue EstimatesAugust 8, 2023 | benzinga.comAzenta Earnings PreviewAugust 3, 2023 | finance.yahoo.comAzenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and WebcastJuly 27, 2023 | seekingalpha.comAzenta: Delivering Solid Growth In Life SciencesJuly 24, 2023 | finance.yahoo.comIs Now An Opportune Moment To Examine Azenta, Inc. (NASDAQ:AZTA)?July 12, 2023 | benzinga.comWatching Azenta Shares; Traders Circulate Activist Insight Rumor Co Said To Attract Activist InvestorJune 29, 2023 | fool.comAzenta (NASDAQ: AZTA)June 29, 2023 | finance.yahoo.comAzenta Announces New Biorepository in the Greater Boston AreaJune 22, 2023 | finance.yahoo.comHere’s Why Polen Capital Global SMID Company Growth Strategy Sold Azenta (AZTA)June 16, 2023 | seekingalpha.comAzenta: A Second AssessmentJune 6, 2023 | finance.yahoo.comAzenta Insiders Added US$752k Of Stock To Their HoldingsMay 31, 2023 | markets.businessinsider.comVazyme Signs Global Strategic Cooperation Agreement with AzentaMay 25, 2023 | finance.yahoo.comAzenta (AZTA) Declined on Weak Management GuidanceSee More Headlines Receive AZTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter. Email Address AZTA Company Calendar Last Earnings8/08/2023Today9/22/2023Fiscal Year End9/30/2023Next Earnings (Estimated)11/13/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Special industry machinery, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AZTA CUSIPN/A CIK933974 Webwww.brooks.com Phone(978) 262-2400Fax978-262-2500Employees3,100Year FoundedN/APrice Target and Rating Average Stock Price Forecast$64.50 High Stock Price Forecast$70.00 Low Stock Price Forecast$55.00 Forecasted Upside/Downside+33.7%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.52) Trailing P/E RatioN/A Forward P/E Ratio371.08 P/E GrowthN/ANet Income$2.13 billion Net Margins-6.09% Pretax Margin-4.47% Return on Equity0.84% Return on Assets0.75% Debt Debt-to-Equity RatioN/A Current Ratio7.42 Quick Ratio6.72 Sales & Book Value Annual Sales$555.50 million Price / Sales5.23 Cash Flow$1.17 per share Price / Cash Flow41.35 Book Value$44.83 per share Price / Book1.08Miscellaneous Outstanding Shares60,200,000Free Float59,195,000Market Cap$2.90 billion OptionableOptionable Beta1.50 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Stephen S. Schwartz (Age 64)CEO, Pres & Director Comp: $1.17MMr. Lindon G. Robertson (Age 61)Exec. VP & CFO Comp: $1MMr. Jason W. Joseph (Age 52)Sr. VP, Gen. Counsel & Corp. Sec. Comp: $651.75kMs. Vandana Sriram CPA (Age 49)Corp. Controller Comp: $800.2kMr. Robin Vacha (Age 47)Sr. VP of Global Operations Violetta HughesVP & Chief Accounting OfficerMr. Michael PauloVP and Chief Information & Digital OfficerSara SilvermanHead of Investor Relations & Corp. CommunicationsMr. John E. O'Brien (Age 53)Sr. VP of Corp. Devel. Dr. Claribel PurcellSr. VP of Global SalesMore ExecutivesKey CompetitorsICU MedicalNASDAQ:ICUIEnovisNYSE:ENOVAxonicsNASDAQ:AXNXIndiviorNASDAQ:INDVLife Time GroupNYSE:LTHView All CompetitorsInsiders & InstitutionsPortside Wealth Group LLCBought 5,955 shares on 9/1/2023Ownership: 0.010%Virginia Retirement Systems ET ALBought 5,500 shares on 8/22/2023Ownership: 0.009%California State Teachers Retirement SystemSold 7,812 shares on 8/21/2023Ownership: 0.139%Osaic Holdings Inc.Sold 967 shares on 8/21/2023Ownership: 0.053%VitalStone Financial LLCBought 14,292 shares on 8/21/2023Ownership: 0.024%View All Insider TransactionsView All Institutional Transactions AZTA Stock - Frequently Asked Questions Should I buy or sell Azenta stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AZTA shares. View AZTA analyst ratings or view top-rated stocks. What is Azenta's stock price forecast for 2023? 5 equities research analysts have issued 1-year price targets for Azenta's stock. Their AZTA share price forecasts range from $55.00 to $70.00. On average, they anticipate the company's stock price to reach $64.50 in the next twelve months. This suggests a possible upside of 33.7% from the stock's current price. View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts. How have AZTA shares performed in 2023? Azenta's stock was trading at $58.22 at the beginning of 2023. Since then, AZTA stock has decreased by 17.1% and is now trading at $48.24. View the best growth stocks for 2023 here. When is Azenta's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our AZTA earnings forecast. How were Azenta's earnings last quarter? Azenta, Inc. (NASDAQ:AZTA) released its quarterly earnings data on Tuesday, August, 8th. The company reported $0.13 EPS for the quarter, beating analysts' consensus estimates of ($0.03) by $0.16. The business had revenue of $165.95 million for the quarter, compared to analysts' expectations of $153.42 million. Azenta had a negative net margin of 6.09% and a positive trailing twelve-month return on equity of 0.84%. The firm's quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.12 earnings per share. What ETFs hold Azenta's stock? ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC), ROBO Global Robotics & Automation ETF (ROBO), Harbor Health Care ETF (MEDI) and Principal Healthcare Innovators ETF (BTEC).BlackRock Future Innovators ETF (BFTR). What guidance has Azenta issued on next quarter's earnings? Azenta updated its fourth quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of -$0.02-$0.06 for the period, compared to the consensus estimate of -$0.03. The company issued revenue guidance of $155.00 million-$173.00 million, compared to the consensus revenue estimate of $165.72 million. What is Azenta's stock symbol? Azenta trades on the NASDAQ under the ticker symbol "AZTA." Who are Azenta's major shareholders? Azenta's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.44%), Kayne Anderson Rudnick Investment Management LLC (6.90%), Allspring Global Investments Holdings LLC (3.53%), Politan Capital Management LP (3.32%), State Street Corp (3.16%) and JPMorgan Chase & Co. (2.81%). Insiders that own company stock include David C Gray, Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus. View institutional ownership trends. How do I buy shares of Azenta? Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Azenta's stock price today? One share of AZTA stock can currently be purchased for approximately $48.24. How much money does Azenta make? Azenta (NASDAQ:AZTA) has a market capitalization of $2.90 billion and generates $555.50 million in revenue each year. The company earns $2.13 billion in net income (profit) each year or ($0.52) on an earnings per share basis. How many employees does Azenta have? The company employs 3,100 workers across the globe. How can I contact Azenta? Azenta's mailing address is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. The official website for the company is www.brooks.com. The company can be reached via phone at (978) 262-2400, via email at investor@brooks.com, or via fax at 978-262-2500. This page (NASDAQ:AZTA) was last updated on 9/22/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Azenta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.